BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	11	8	10	15	0	0
Market Cap Growth	-49.29%	-18.94%	-33.36%	7042.14%	38.00%	-98.37%
Enterprise Value	-5	-3	-4	-5	2	8
PE Ratio	-	-0.79	-0.76	-0.34	-0.02	-0.01
PS Ratio	74.72	56.17	84.33	329.56	2.76	1.18
PB Ratio	0.77	0.82	0.98	0.70	-0.16	-0.01
P/FCF Ratio	-1.00	-1.24	-1.64	-4.51	-0.11	-0.02
P/OCF Ratio	-1.02	-1.27	-1.71	-4.55	-0.11	-0.02
EV/Sales Ratio	-65.55	-18.62	-37.43	-115.55	23.14	60.81
EV/EBITDA Ratio	1.47	0.27	0.35	0.13	-0.19	-0.61
EV/EBIT Ratio	1.41	0.26	0.34	0.13	-0.18	-0.60
EV/FCF Ratio	1.51	0.41	0.73	1.58	-0.91	-1.14
Debt / Equity Ratio	0.01	0.02	0.02	0.03	-3.48	-0.61
Debt / EBITDA Ratio	-0.02	-0.02	-0.01	-0.01	-0.49	-0.60
Debt / FCF Ratio	-0.02	-0.02	-0.03	-0.16	-2.36	-1.11
Quick Ratio	4.77	4.25	2.47	57.81	2.95	0.00
Current Ratio	4.86	4.37	2.53	59.01	3.05	0.01
Asset Turnover	0.01	0.01	0.01	0.01	0.04	0.08
Interest Coverage	-380.90	-	-	-23.40	-5.87	-8.98
Return on Equity (ROE)	-55.90%	-85.50%	-80.10%	-1734.90%	93.20%	140.20%
Return on Assets (ROA)	-48.30%	-77.50%	-70.80%	-567.70%	-514.30%	-844.20%
Return on Capital (ROIC)	-92.64%	-149.71%	-181.52%	-118.78%	-83.34%	167.87%
Earnings Yield	-62.28%	-127.21%	-130.88%	-292.25%	-5310.92%	-9523.49%
FCF Yield	-58.28%	-80.61%	-61.16%	-22.17%	-925.43%	-4521.46%
Buyback Yield / Dilution	-79.46%	-16.60%	-204.60%	-200.92%	-6987.54%	99.71%
Total Shareholder Return	-79.46%	-16.60%	-204.60%	-200.92%	-6987.54%	99.71%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).